ETrade Capital Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q3 | $4.12M | Sell |
75,189
-12,187
| -14% | -$668K | 0.08% | 132 |
|
2020
Q2 | $4.62M | Buy |
87,376
+43,253
| +98% | +$2.29M | 0.1% | 106 |
|
2020
Q1 | $1.97M | Sell |
44,123
-6,926
| -14% | -$309K | 0.05% | 196 |
|
2019
Q4 | $2.55M | Buy |
51,049
+3,138
| +7% | +$156K | 0.06% | 186 |
|
2019
Q3 | $2.14M | Buy |
47,911
+154
| +0.3% | +$6.86K | 0.05% | 207 |
|
2019
Q2 | $1.97M | Sell |
47,757
-24,417
| -34% | -$1.01M | 0.05% | 212 |
|
2019
Q1 | $2.92M | Sell |
72,174
-31,218
| -30% | -$1.26M | 0.08% | 140 |
|
2018
Q4 | $3.93M | Sell |
103,392
-11,866
| -10% | -$451K | 0.13% | 85 |
|
2018
Q3 | $4.56M | Buy |
115,258
+13,944
| +14% | +$552K | 0.13% | 88 |
|
2018
Q2 | $3.56M | Sell |
101,314
-8,968
| -8% | -$315K | 0.11% | 104 |
|
2018
Q1 | $3.86M | Sell |
110,282
-8,901
| -7% | -$311K | 0.12% | 88 |
|
2017
Q4 | $4.14M | Buy |
119,183
+3,110
| +3% | +$108K | 0.13% | 86 |
|
2017
Q3 | $3.93M | Buy |
116,073
+30,435
| +36% | +$1.03M | 0.14% | 79 |
|
2017
Q2 | $2.92M | Buy |
85,638
+65
| +0.1% | +$2.22K | 0.11% | 98 |
|
2017
Q1 | $2.67M | Buy |
85,573
+29,887
| +54% | +$931K | 0.11% | 108 |
|
2016
Q4 | $1.52M | Sell |
55,686
-11,255
| -17% | -$307K | 0.07% | 162 |
|
2016
Q3 | $2.2M | Buy |
66,941
+45,820
| +217% | +$1.51M | 0.11% | 120 |
|
2016
Q2 | $638K | Buy |
21,121
+7,662
| +57% | +$231K | 0.03% | 297 |
|
2016
Q1 | $379K | Buy |
13,459
+5,196
| +63% | +$146K | 0.02% | 352 |
|
2015
Q4 | $281K | Buy |
+8,263
| New | +$281K | 0.02% | 387 |
|
2014
Q2 | – | Sell |
-4,966
| Closed | -$161K | – | 451 |
|
2014
Q1 | $161K | Sell |
4,966
-18
| -0.4% | -$584 | 0.01% | 350 |
|
2013
Q4 | $148K | Sell |
4,984
-1,312
| -21% | -$39K | 0.01% | 317 |
|
2013
Q3 | $163K | Buy |
6,296
+2,296
| +57% | +$59.4K | 0.02% | 282 |
|
2013
Q2 | $95K | Buy |
+4,000
| New | +$95K | 0.01% | 321 |
|